Role of Hydrogen Peroxide in the Aetiology of Alzheimer??s Disease
- 1 January 2004
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 21 (2) , 81-100
- https://doi.org/10.2165/00002512-200421020-00002
Abstract
Hydrogen peroxide (H2O2) is a stable, uncharged and freely diffusable reactive oxygen species (ROS) and second messenger. The generation of H2O2 in the brain is relatively high because of the high oxygen consumption in the tissue. Alzheimer’s disease is a neurodegenerative disorder characterised by the appearance of amyloid-β (Aβ)-containing plaques and hyperphosphorylated tau-containing neurofibrillary tangles. The pathology of Alzheimer’s disease is also associated with oxidative stress and H2O2 is implicated in this and the neurotoxicity of the Aβ peptide. The ability for Aβ to generate H2O2, and interactions of H2O2 with iron and copper to generate highly toxic ROS, may provide a mechanism for the oxidative stress associated with Alzheimer’s disease. The role of heavy metals in Alzheimer’s disease pathology and the toxicity of the H2O2 molecule may be closely linked. Drugs that prevent oxidative stress include antioxidants, modifiers of the enzymes involved in ROS generation and metabolism, metal chelating agents and agents that can remove the stimulus for ROS generation. In Alzheimer’s disease the H2O2 molecule must be considered a therapeutic target for treatment of the oxidative stress associated with the disease. The actions of H2O2 include modifications of proteins, lipids and DNA, all of which are effects seen in the Alzheimer’s disease brain and may contribute to the loss of synaptic function characteristic of the disease. The effectiveness of drugs to target this component of the disease pathology remains to be determined; however, metal chelators may provide an effective route and have the added bonus in the case of clioquinol of potentially reducing the Aβ load. Future research and development of agents that specifically target the H2O2 molecule or enzymes involved in its metabolism may provide the future route to Alzheimer’s disease therapy.Keywords
This publication has 232 references indexed in Scilit:
- Anandamide and noladin ether prevent neurotoxicity of the human amyloid-β peptideNeuroscience Letters, 2002
- Implication of Novel Biochemical Property of β-AmyloidBiochemical and Biophysical Research Communications, 2000
- Basic Fibroblast Growth Factor Stimulation of Glial Cells Protects Dopamine Neurons from 6‐Hydroxydopamine Toxicity: Involvement of the Glutathione SystemJournal of Neurochemistry, 1997
- Oxidative damage in Alzheimer'sNature, 1996
- The Role of Iron in Beta Amyloid ToxicityBiochemical and Biophysical Research Communications, 1995
- β-Amyloid Peptide Free Radical Fragments Initiate Synaptosomal Lipoperoxidation in a Sequence-Specific Fashion: Implications to Alzheimer′s DiseaseBiochemical and Biophysical Research Communications, 1994
- Tau protein and the neurofibrillary pathology of Alzheimer's diseaseTrends in Neurosciences, 1993
- Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changesNeuroscience Letters, 1993
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Alzheimer neurofibrillary tangles contain phosphorylated and hidden neurofilament epitopes.Journal of Neurology, Neurosurgery & Psychiatry, 1986